GCNT1P3

Across TCGA pan-cancer cohorts, GCNT1P3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated GCNT1P3 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher GCNT1P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GCNT1P3 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

KIRC, MESO, and LGG are the cancer types where GCNT1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	All	0.794	0.896	.003	80	view →
MESO	OS	Median	II,III,IV	0.281	0.488	.001	52	view →
LGG	DFS	Tertile	All	0.752	0.863	<.001	37	view →
ESCA	DFS	Quartile	III,IV	0.566	0.348	.002	25	view →
THCA	OS	Tertile	II,III,IV	0.952	1.000	.007	25	view →
LUAD	OS	Median	III,IV	0.630	0.306	.008	23	view →
BLCA	DFS	Quartile	III,IV	0.449	0.575	.016	18	view →
STAD	DFS	Quartile	IV	0.146	0.528	.005	18	view →
SKCM	OS	Median	II,III,IV	0.903	0.770	.007	13	view →
HNSC	DFS	Median	All	0.666	0.751	.010	12	view →
KIRP	OS	Quartile	II,III,IV	0.552	0.788	.017	10	view →
ACC	DFS	Tertile	III,IV	0.108	0.426	.048	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

GCNT1P3–KIRC (OS)

Open the KIRC breakdown →